University of California, Davis: Breast Neoplasms trials
The registry lists 17 Breast Neoplasms studies with University of California, Davis as lead sponsor. 4 are open to participants now and 3 have results posted.
Early Phase 1 1Phase 1 4Phase 2 2No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- UHFUS Characterization of Normal Lymphatic AnatomyRecruitingNCT07677839Not applicable
- Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyRecruitingNCT06268665Phase 2
- Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)RecruitingNCT06103669Not applicable
- A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDGEnrolling by invitationNCT05160480
- Computed Tomography Versus Standard 2D Mammography Versus 3D TomosynthesisCompletedNCT01852032Not applicableResults posted
- Evaluation of Breast CTCompletedNCT00584233Not applicableResults posted
- Abraxane and Alimta in Advanced Solid TumorsTerminatedNCT00470548Phase 1/2Results posted
- Geriatric Assessment and Promotores (GAP) Pilot Feasibility StudyCompletedNCT06125145Not applicable
- Assessing Breast Density's Value in Imaging - A Comparative Effectiveness StudyStatus unknownNCT02980848
- Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast CancerCompletedNCT02366806
- Oxaliplatin in Treating Patients With Metastatic Breast CancerCompletedNCT02077998Early Phase 1
- Blood Glycan Biomarkers in Women With Stage IV Breast CancerCompletedNCT00897962
- Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00859157
- Molecular Imaging of Breast Cancer With Breast PET/CTTerminatedNCT00584753Phase 1
- Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in SituCompletedNCT00388115Not applicable
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast CancerStatus unknownNCT00009763Phase 1
- Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast CancerStatus unknownNCT00003920Phase 1